Developing next generation precision drugs inspired by nature
Centre research summary: We are focused on the design and discovery of new medicines to treat the world’s greatest disease challenges, including cardiovascular disease, stroke, cancer, inflammatory and respiratory diseases, neurological disorders, and to relieve chronic pain and suffering. This work also supports the development of new medicines for animal health and eco-friendly insecticides to protect agriculture.
We develop new clues for drug design by:
identifying mechanisms of disease development and drug action.
discovering biologically active natural products from plants, animals, and microbes in soil.
studying structures and actions of disease-causing proteins as potential drug targets.
creating new technologies to drive the discovery and development of drugs, growing medicines in plants and microalgae, and monitor drug candidates and their targets in disease.
Our multidisciplinary team has broad and deep experience in Chemistry, Biochemistry, Molecular and Structural Biology, Pharmacology, Immunology, translation and commercialisation and integrates this to define the processes that control life, ageing, disease and death and use this information to guide the development of new treatments.
The Centre has translated its research into drugs in clinical trials, insecticides for agricultural applications, and animal baits for pest control.

Professor Ben Hankamer
Acting Director, Centre for Chemistry and Drug Discovery
Contact the Centre
+61 7 334 62989
ctr-cdd-admin@imb.uq.edu.au
Expertise
- Chemistry
- Biochemistry
- Pharmacology
- Immunology
- Proteomics
- Protein structure and function
- Structure-based drug design
- Drug discovery and development
- Drug targets
- Natural products
- Synthetic compounds
- In silico compounds
- Signaling pathways and mechanisms
Disease focus
- Heart disease
- Cancer
- Stroke
- Chronic inflammatory diseases
- Dementia
- Diabetes and metabolic disorders
- Respiratory disease
- Chronic liver disease
- Kidney disease
- Neurological disorders
- Chronic pain
Research Groups
Protein structure in drug and insecticide design
Professor David CraikChemistry and human therapeutics
Professor David FairlieBioinspired design of solar biotechnology systems
Professor Ben HankamerBugs and drugs
Professor Glenn KingPharmacology of marine toxins
Professor Richard LewisNeuropeptide research
Associate Professor Markus MuttenthalerCombinatorial chemistry and molecular design
Associate Professor Mark Smythe
Discovering new ways to make better cancer drugs
Dr Conan WangMolecular mechanisms of blood-brain barrier transport
Dr Rosemary Cater
General enquiries
+61 7 3346 2222
imb@imb.uq.edu.au
Media enquiries
IMB fully supports UQ's Reconciliation Action Plan and is implementing actions within our institute.
Support us
Donate to research
100% of donations go to the cause











